Apeced syndrome or autoimmune polyendocrine syndrome Type 1;Syndrome Apeced ou polyendocrinopathie auto-immune de type 1

Presse Medicale

Volumn 37, Issue 7-8, 2008, Pages 1158-1171

  Proust Lemoine, Emmanuelle ^a,b   Wémeau, Jean Louis ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Centre de Biologie Pathologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADDISON DISEASE; ADRENAL INSUFFICIENCY; ALOPECIA; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNITY; AUTOSOMAL RECESSIVE INHERITANCE; CANDIDIASIS; ECHOGRAPHY; ENDOCRINE DISEASE; GASTRITIS; GENE MUTATION; HEPATITIS; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOPARATHYROIDISM; IMMUNE DYSREGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KERATINIZATION; KERATOCONJUNCTIVITIS; LIFE EXPECTANCY; MALABSORPTION; MUCOCUTANEOUS CANDIDIASIS; PHENOTYPE; PSEUDOHYPOPARATHYROIDISM; RARE DISEASE; SHORT SURVEY; SIBLING; THYROIDITIS; VITILIGO;

ADDISON DISEASE; CANDIDIASIS, CHRONIC MUCOCUTANEOUS; CAUSE OF DEATH; DNA-BINDING PROTEINS; GENES, RECESSIVE; HUMANS; HYPOPARATHYROIDISM; MUTATION; PHENOTYPE; POLYENDOCRINOPATHIES, AUTOIMMUNE; PROGNOSIS; TRANSCRIPTION FACTORS; ZINC FINGERS;

EID: 45649084718     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2007.11.015     Document Type: Short Survey

References (41)

1. Whitaker J., Landing B.H., Esselborn V.M., and Williams R.R. The syndrome of familial juvenile hypoadrenocorticism, hypoparathyroidism and superficial moniliasis. J Endocrinol 16 (1956) 1374-1387
2. Neufeld M., Maclaren N., and Blizzard R. Autoimmune polyglandular syndromes. Pediatr Ann 9 (1980) 154-162
3. Ahonen P. Autoimmune polyendocrinopathy--candidosis--ectodermal dystrophy (Apeced): autosomal recessive inheritance. Clin Genet 27 (1985) 535-542
4. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27 (2001) 20-21
5. Ahonen P., Myllarniemi S., Sipila I., and Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (Apeced) in a series of 68 patients. N Engl J Med 322 (1990) 1829-1836
6. Rosatelli M.C., Meloni A., Meloni A., Devoto M., Cao A., Scott H.S., et al. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum Genet 103 (1998) 428-434
7. Zlotogora J., and Shapiro M.S. Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet 29 (1992) 824-826
8. Wolff A.S., Erichsen M.M., Meager A., Magitta N.F., Myhre A.G., Bollerslev J., et al. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway - phenotypic variation, autoantibodies and novel mutations in the autoimmune regulator (AIRE) gene. J Clin Endocrinol Metab 92 (2007) 595-603
9. Proust-Lemoine E., Cardot-Bauters C., Saugier-Véber P., Lefebvre H., Lalau J.D., Reznik Y., et al. Evaluation clinique, immunologique et génétique du syndrome Apeced dans le Nord-Ouest de la France : à propos de 18 observations. Ann Endocrino (Paris) 68 (2007) 1S19
10. The Finnish-German Apeced Consortium. An autoimmune disease, Apeced, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy. Nat Genet 17 (1997) 399-403
11. Nagamine K., Peterson P., Scott H.S., Kudoh J., Minoshima S., Heino M., et al. Positional cloning of the Apeced gene. Nat Genet 17 (1997) 393-398
12. Heino M., Peterson P., Kudoh J., Nagamine K., Lagerstedt A., Ovod V., et al. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem Biophys Res Commun 257 (1999) 821-825
13. Meloni A., Perniola R., Faa V., Corvaglia E., Cao A., and Rosatelli M.C. Delineation of the molecular defects in the AIRE gene in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients from Southern Italy. J Clin Endocrinol Metab 87 (2002) 841-846
14. Bjorses P., Halonen M., Palvimo J.J., Kolmer M., Aaltonen J., Ellonen P., et al. Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am J Hum Genet 66 (2000) 378-392
15. Anderson M.S., Venanzi E.S., Klein L., Chen Z., Berzins S.P., Turley S.J., et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 298 (2002) 1395-1401
16. Liston A., Lesage S., Wilson J., Peltonen L., and Goodnow C.C. AIRE regulates negative selection of organ-specific T cells. Nat Immunol 4 (2003) 350-354
17. Gavanescu I., Kessler B., Ploegh H., Benoist C., and Mathis D. Loss of AIRE-dependent thymic expression of a peripheral tissue antigen renders it a target of autoimmunitY. Proc Natl Acad Sci U S A 104 (2007) 4583-4587
18. Ramsey C., Hassler S., Marits P., Kampe O., Surh C.D., Peltonen L., et al. Increased antigen presenting cell-mediated T cell activation in mice and patients without the autoimmune regulator. Eur J Immunol 36 (2006) 305-317
19. Kekalainen E., Tuovinen H., Joensuu J., Gylling M., Franssila R., Pontynen N., et al. A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Immunol 178 (2007) 1208-1215
20. Brannstrom J., Hassler S., Peltonen L., Herrmann B., and Winqvist O. Defect internalization and tyrosine kinase activation in AIRE deficient antigen presenting cells exposed to Candida albicans antigens. Clin Immunol 121 (2006) 265-273
21. Perheentupa J. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy. J Clin Endocrinol Metab 91 (2006) 2843-2850
22. Betterle C., Greggio N.A., and Volpato M. Clinical review 93: Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 83 (1998) 1049-1055
23. Myhre A.G., Halonen M., Eskelin P., Ekwall O., Hedstrand H., Rorsman F., et al. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway. Clin Endocrinol (Oxf) 54 (2001) 211-217
24. Collins S.M., Dominguez M., Ilmarinen T., Costigan C., and Irvine A.D. Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Br J Dermatol 154 (2006) 1088-1093
25. Ekwall O., Hedstrand H., Grimelius L., Haavik J., Perheentupa J., Gustafsson J., et al. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 352 (1998) 279-283
26. Hogenauer C., Meyer R.L., Netto G.J., Bell D., Little K.H., Ferries L., et al. Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I. N Engl J Med 344 (2001) 270-274
27. Soderbergh A., Myhre A.G., Ekwall O., Gebre-Medhin G., Hedstrand H., Landgren E., et al. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 89 (2004) 557-562
28. Perniola R., Falorni A., Clemente M.G., Forini F., Accogli E., and Lobreglio G. Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (Apeced). Eur J Endocrinol 143 (2000) 497-503
29. Bensing S., Fetissov S.O., Mulder J., Perheentupa J., Gustafsson J., Husebye E.S., et al. Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1. Proc Natl Acad Sci U S A 104 (2007) 949-954
30. Ekwall O., Hedstrand H., Haavik J., Perheentupa J., Betterle C., Gustafsson J., et al. Pteridin-dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 85 (2000) 2944-2950
31. Skoldberg F., Portela-Gomes G.M., Grimelius L., Nilsson G., Perheentupa J., Betterle C., et al. Histidine Decarboxylase, a Pyridoxal Phosphate-Dependent enzyme, is an autoantigen of gastric enterochromaffin-like cells. J Clin Endocrinol Metab 88 (2003) 1445-1452
32. Obermayer-Straub P., Perheentupa J., Braun S., Kayser A., Barut A., Loges S., et al. Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Gastroenterology 121 (2001) 668-677
33. Hedstrand H., Ekwall O., Olsson M.J., Landgren E., Kemp E.H., Weetman A.P., et al. The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I. J Biol Chem 276 (2001) 35390-35395
34. Hedstrand H., Ekwall O., Haavik J., Landgren E., Betterle C., Perheentupa J., et al. Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. Biochem Biophys Res Commun 267 (2000) 456-461
35. Meager A., Visvalingam K., Peterson P., Moll K., Murumagi A., Krohn K., et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome Type 1. PLoS Med 3 (2006) e289
36. Halonen M., Eskelin P., Myhre A.G., Perheentupa J., Husebye E.S., Kampe O., et al. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. J Clin Endocrinol Metab 87 (2002) 2568-2574
37. Perheentupa J. APS-I/Apeced: the clinical disease and therapy. Endocrinol Metab Clin North Am 31 (2002) 295-320
38. Padeh S., Theodor R., Jonas A., and Passwell J.H. Severe malabsorption in autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome successfully treated with immunosuppression. Arch Dis Child 76 (1997) 532-534
39. Lankisch T.O., Strassburg C.P., Debray D., Manns M.P., and Jacquemin E. Detection of autoimmune regulator gene mutations in children with type 2 autoimmune hepatitis and extrahepatic immune-mediated diseases. J Pediatr 146 (2005) 839-842
40. Ward L., Paquette J., Seidman E., Huot C., Alvarez F., Crock P., et al. Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J Clin Endocrinol Metab 84 (1999) 844-852
41. Ulinski T., Perrin L., Morris M., Houang M., Cabrol S., Grapin C., et al. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome with renal failure: impact of posttransplant immunosuppression on disease activity. J Clin Endocrinol Metab 91 (2006) 192-195